Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet treatment for managing HIV infection. This drug integrates three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to replicate within the body, remarkably reducing the viral load. For